Molecular Epidemiology of Human Papillomaviruses, Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium among Female Sex Workers in Burkina Faso: Prevalence, Coinfections and Drug Resistance Genes
- PMID: 34072200
- PMCID: PMC8163177
- DOI: 10.3390/tropicalmed6020090
Molecular Epidemiology of Human Papillomaviruses, Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium among Female Sex Workers in Burkina Faso: Prevalence, Coinfections and Drug Resistance Genes
Abstract
Viral and bacterial infections represent an occupational risk for female sex workers. This study aimed at determining HPV coinfection with genital pathogens among female sex workers in West and Central Africa and identifying antibiotic resistance genes. A total of 182 samples from female sex workers were analyzed by real-time PCR and classic PCR. For the molecular diagnosis of HPV, the real-time multiplex amplification kit "HPV Genotypes 14 Real-TM Quant" from SACACE Biotechnologies®, detecting 14 high-risk HPV genotypes, was used, while for other pathogens, the real-time multiplex amplification kit N. gonorrhoeae/C. trachomatis/M. genitalium/T. vaginalis Real-TM, allowing their simultaneous detection, was used. The women were aged 17-50 years with an average age of 27.12 ± 6.09 years. The pathogens identified were HPV 54.94% (100/120), Neisseria gonorrhoeae (13.74%), Chlamydia trachomatis (11.54%) and Mycoplasma genitalium (11.54%). The most common HPV genotypes were HPV68, HPV38 and HPV52. The antibiotic resistance genes identified were bla QNR B 24.00%, bla GES 22.00%, bla SHV 17.00%, blaCTX-M 13.00% and bla QNR S 1.00%. This study revealed the presence of various HPV genotypes associated with other pathogens with problems of antibiotic resistance among sex workers of West and Central African origin working in Ouagadougou.
Keywords: HPV; Neisseriae gonorrhoeae; PCR; STIs; resistance genes; sex workers.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- World Health Organization . Report on Global Sexually Transmitted Infection Surveillance. WHO/OMS; Geneva, Switzerland: 2018.
-
- World Health Organization . Stratégie Mondiale du Secteur de la Santé Contre Les Infections Sexuellement Transmissibles 2016–2021. WHO/OMS; Geneva, Switzerland: 2016.
-
- Rowley J., Vander H.S., Korenromp E., Low N., Unemo M., Abu-Raddad L.J., Chico R.M., Smolak A., Newman L., Gottlieb S., et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: Global prevalence and incidence estimates, 2016. Bull. World Health Organ. 2019;97:548. doi: 10.2471/BLT.18.228486. - DOI - PMC - PubMed
-
- Woodhall S.C., Wills G.S., Horner P.J., Craig R., Mindell J.S., Murphy G., McClure M.O., Soldan K., Nardone A., Johnson A.M. Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994–2012) PLoS ONE. 2017;12:e0152810. doi: 10.1371/journal.pone.0152810. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
